Invesco Ltd. Pmv Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.51 - $3.12 $1,013 - $2,093	-671 Reduced 5.6%	11,315 $19,000
Q4 2023 Feb 12, 2024	BUY	$1.23 - $6.6 $14,742 - $79,107	11,986 New	11,986 $37,000
Q4 2022 Feb 13, 2023	SELL	$8.17 - $12.95 $506 - $802	-62 Reduced 0.57%	10,800 $93,000
Q3 2022 Nov 14, 2022	SELL	$11.4 - $17.18 $1,003 - $1,511	-88 Reduced 0.8%	10,862 $129,000
Q2 2022 Aug 15, 2022	SELL	$9.23 - $22.43 $1,402 - $3,409	-152 Reduced 1.37%	10,950 $157,000
Q1 2022 May 16, 2022	BUY	$14.86 - $23.55 $4,235 - $6,711	285 Added 2.63%	11,102 $231,000
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $3.24 Million - $4.9 Million	-161,909 Reduced 93.74%	10,817 $249,000
Q3 2021 Nov 15, 2021	SELL	$26.84 - $36.58 $1.2 Million - $1.63 Million	-44,538 Reduced 20.5%	172,726 $5.15 Million
Q2 2021 Aug 17, 2021	SELL	$28.01 - $36.01 $662,576 - $851,816	-23,655 Reduced 9.82%	217,264 $7.42 Million
Q1 2021 May 17, 2021	SELL	$30.66 - $49.5 $2.01 Million - $3.25 Million	-65,590 Reduced 21.4%	240,919 $7.92 Million
Q4 2020 Feb 16, 2021	SELL	$31.86 - $61.51 $2.98 Million - $5.75 Million	-93,491 Reduced 23.37%	306,509 $18.9 Million
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $14.2 Million - $15.2 Million	400,000 New	400,000 $14.2 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.